| Extent and impact of late vs early stage COPD diagnosis in a Swedish cohort: The ARCTIC study. |
| Author(s): Larsson K, Janson C, Ställberg B, Lisspers K, Olsson P, Kostikas K, Uhde M, Jorgensen L, Gutzwiller F S, Johansson G. |
| Affiliations(s): |
| Publication(s): Nordic Lung Congress 2017, 10-12 May Visby Sweden |
| Document Type(s): Abstract |
| Countries: Sweden |
C:
Y: |
Respiratory disease
2017 |
|
L:
A: |
English
Real World Evidence |
|
 |
| |
| |
| Comorbidities in Swedish COPD and non-COPD patients: ARCTIC study. |
| Author(s): Ställberg B, Janson C, Larsson K, Johansson G, Kostikas K, Gruenberger J-B, Gutzwiller F S, Jorgensen L, Uhde M, Lisspers K. |
| Affiliations(s): |
| Publication(s): Nordic Lung Congress 2017, 10-12 May, Visby Sweden |
| Document Type(s): |
| Countries: Sweden |
C:
Y: |
Respiratory disease
2017 |
|
L:
A: |
English
Real World Evidence |
|
|
| |
| |
| An observation of prescription behaviors and adherence to guidelines in patients with COPD: real world data from October 2012 to September 2014. |
| Author(s): Visentin E1, Nieri D2, Vagaggini B2, Peruzzi E3, Paggiaro P2. |
| Affiliations(s): 1 IMS Health Information Solutions Italy srl, Milan, Italy 2 Cardio-Thoracic and Vascular Department, University of Pisa, Pisa, Italy 3 Novartis Farma Spa, Origgio, Italy |
| Publication(s): Curr Med Res Opin. 24:1-10 |
| Document Type(s): Article |
| Countries: Italy |
| Click here for the abstract |
C:
Y: |
Respiratory disease
2016 |
|
L:
A: |
English
Real World Data, Retrospective database analysis |
|
|
| |
| |
| The economic burden of COPD in a Swedish cohort: The ARCTIC study |
| Author(s): Karin Lisspers1, Kjell Larsson2, Gunnar Johansson1, Christer Janson1,
Madlaina Costa-Scharplatz3, Jean-Bernard Gruenberger3, Milica Uhde4,
Leif Jorgensen4, Patrik Sobocki2,4, Björn Ställberg2 4 |
| Affiliations(s): 1Uppsala University, Sweden, 2Karolinska Institutet, Sweden, 3Novartis Pharma AG,
Sweden, 4IMS Health |
| Publication(s): NPJ Primary Care Respiratory Medicine |
| Document Type(s): Abstract |
| Countries: Sweden |
| Click here for the abstract |
C:
Y: |
Respiratory disease
2016 |
|
L:
A: |
English
Real World Evidence |
|
|
| |
| |
| The prevalence of comorbidities in Swedish COPD and non-COPD patients: The ARCTIC study |
| Author(s): Bjorn Stallberg1, Christer Janson1, Kjell Larsson2, Gunnar Johansson1,
Konstantinos Kostikas3, Jean-Bernard Gruenberger3, Leif Jorgensen4,
Patrik Sobocki2 4, Karin Lisspers1 |
| Affiliations(s): 1Uppsala University, Sweden, 2Karolinska Institutet, Sweden, 3Novartis Pharma AG,
Sweden, 4IMS Health Sweden |
| Publication(s): NPJ Primary Care Respiratory Medicine |
| Document Type(s): Abstract |
| Countries: Sweden |
| Click here for the abstract |
C:
Y: |
Respiratory disease
2016 |
|
L:
A: |
English
Real World Evidence |
|
|
| |
| |
| ICS and risk of pneumonia in Swedish COPD patients: ARCTIC study |
| Author(s): Christer Janson1, Gunnar Johansson1, Björn Ställberg1, Karin Lisspers1,
Petter Olsson2, Dorothy Keininger2, Leif Jorgensen3, Patrik Sobocki3 4,
Kjell Larsson4 |
| Affiliations(s): 1Uppsala University, Sweden, 2Novartis Pharma AG, Sweden, 3IMS Health, Sweden,
4Karolinska Institutet, Sweden |
| Publication(s): NPJ Primary Care Respiratory Medicine |
| Document Type(s): Abstract |
| Countries: Sweden |
| Click here for the abstract |
C:
Y: |
Respiratory disease
2016 |
|
L:
A: |
English
Real World Evidence |
|
|
| |
| |
| STATISTICAL MODELS TO PREDICT INDICATION OF RESPIRATORY PATIENTS BETWEEN ASTHMA AND COPD |
| Author(s): Ilgin Y, Staus A, Chauvin F, Leheyda N, Wolk A, Witte M, Subramani S |
| Affiliations(s): |
| Publication(s): 19th ISPOR congress 2016 |
| Document Type(s): Abstract, Poster |
| Countries: France |
C:
Y: |
Health status & patient reported outcomes, Methodology, Respiratory disease
2016 |
|
L:
A: |
English
Methodology, Retrospective database analysis |
|
|
| |
| |
| Patterns of Roflumilast Use for the Treatment of COPD Across Three Distinct Populations: Findings from the Roflumilast PASS Study |
| Author(s): Knox C, Mountford W, Kaufman E, et al. |
| Affiliations(s): |
| Publication(s): 32nd International Conference on Pharmacoepidemiology and Therapeutic Risk Management; 2016; Dublin, Ireland |
| Document Type(s): Abstract |
| Countries: Germany, Sweden, USA |
C:
Y: |
Respiratory disease
2016 |
|
L:
A: |
English
Epidemiological study, Real World Evidence |
|
|
| |
| |
| COPD Patients Initiating Roflumilast in Sweden, Germany and the United States: Findings from the Roflumilast PASS Study |
| Author(s): Hoti F, Mushnikov V, Mehtälä J, et al. |
| Affiliations(s): |
| Publication(s): 32nd International Conference on Pharmacoepidemiology and Therapeutic Risk Management; 2016; Dublin, Ireland |
| Document Type(s): Abstract |
| Countries: Germany, Sweden, USA |
C:
Y: |
Respiratory disease
2016 |
|
L:
A: |
English
Real World Evidence |
|
|
| |
| |
| Clinical and economic factors associated with spirometry-diagnosed COPD in the Swedish ARCTIC study |
| Author(s): Gunnar Johansson (1), Gunnar Johansson, Kjell Larsson, Björn Ställberg, Karin Lisspers, Petter Olsson, Jean-Bernard Gruenberger, Leif Jorgensen, Patrik Sobocki, Christer Janson |
| Affiliations(s): 1 Uppsala, Sweden |
| Publication(s): Eur Respir J |
| Document Type(s): Abstract |
| Countries: Sweden |
| Click here for the abstract |
C:
Y: |
Respiratory disease
2016 |
|
L:
A: |
English
Real World Evidence |
|
|
| |
| |
 1 of 19 
|
